within the striatum , calcineurin activity does not appear to be present in dopaminergic terminals , since lesions of the nigro-striatal dopaminergic pathway ( which reduce striatal dopamine levels by 97 % ) had no effect on calcineurin activity .
C0282151
dopaminergic
C0013030
dopamine